In fresh troubles for Uber, the Competition Appellate Tribunal (Compat) has ordered fair trade watchdog Competition Commission of India (CCI) to probe afresh the alleged abuse of dominance by the popular taxi-hailing app operator.
The latest direction comes after Meru Travels Solutions approached the tribunal against CCI’s earlier decision against ordering an investigation into allegations against Uber of unfair practices including predatory pricing.
In an order dated 7 December, the tribunal has directed CCI’s probe unit director general (DG) to conduct a fresh probe into the allegations of abuse of dominance and anti- competitive practices by Uber.
“The size of discounts and incentives shows there are either phenomenal efficiency improvements which are replacing existing business models with the new business models or there could be an anti-competitive stance to it,” Compat said.
“In our view, there is a good enough reason for the director general to investigate this matter. It will also help in settling an issue which has agitated business discourse for quite some time,” the tribunal added.
It also asked CCI to pass appropriate order, on receipt of the investigation report, after giving opportunity to all parties to file their replies or objections and affording them opportunity of personal hearing.
Full Content: Live Mint
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas